Posted on 27/06/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study
Posted on 6/06/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces three new appointments to its management board, forming part of ongoing growth and development in
Posted on 5/04/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s
Posted on 25/03/2024
Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, is proud to introduce their latest packaging, updated to reduce their carbon footprint, as a contribution to
Posted on 23/01/2024
Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor
Posted on 16/01/2024
17/01/2024 | Rayner, a global leader in products for cataract surgery, headquartered in Worthing, UK, announces today that it has entered into a definitive agreement to acquire Swiss-based This AG,
Posted on 21/12/2023
Rayner, a global manufacturer of products for cataract surgery, is delighted to have scored within the top 17% of companies in the 2023 EcoVadis ratings. EcoVadis is the world’s largest
Posted on 14/12/2023
Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, has introduced a number of beehives to their site to contribute towards their environmental and social responsibility
Posted on 4/09/2023
Worthing, United Kingdom – Rayner, a pioneering leader in ophthalmic innovation, is thrilled to announce a series of ground-breaking updates to its digital platforms, RayPRO and Peer2Peer, set to redefine
Posted on 11/08/2023
Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two